Continuing education credits are jointly provided by Postgraduate Institute for Medicine (PIM) and the Alzheimer’s Association, and are available to all AAIC 2023 attendees at no cost. More information about AAIC 2024 continuing education credit will be available in the coming months.

Contact the Postgraduate Institute for Medicine (PIM) for questions about CE credits at inquiries@pimed.com.

On This Page:

• > Target Audience
• > Educational Objectives
• > Joint Accreditation Statement
• > Physicians
• > Pharmacists
• > Psychologists
• > Nurses
• > Social Workers
• > Disclosure of Conflicts of Interest
• > Disclosure of Unlabeled Use
• > Disclaimer
• > How to Claim Credit

Target Audience

This activity is intended for biochemists, geriatric psychiatrists, geriatric specialists, molecular and cell biologists, neurologists, neuroscientists, nurses, pharmacologists, primary care physicians, psychiatrists, psychologists, radiologists and social workers involved in the research and/or care of people with Alzheimer’s and other dementias.

Educational Objectives

After completing this activity, the participant should be better able to:

• Utilize advances in technology, including imaging and biomarkers to improve diagnosis and monitor disease progression in Alzheimer’s disease.
• Review data on current animal models for Alzheimer's disease.
• Compare the pathophysiology of aging, Alzheimer's disease and other geriatric syndromes.
• Identify potential targets for treatment of Alzheimer's disease.
• Discuss recommendations for the prevention of Alzheimer's disease.
• Explain therapeutic breakthroughs in neurodegenerative disease.
• Identify emerging strategies likely to drive future advances in Alzheimer's disease.
• Describe the impact of Alzheimer's on individuals with the disease and their caregivers.
• Indicate how Alzheimer's disease affects society as it relates to health economics.

Faculty: Wiesje van der Flier and Sergio Ferreira of the AAIC Scientific Program Committee.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine (PIM) and the Alzheimer’s Association. PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Alzheimer’s Association International Conference, Amsterdam, Netherlands, 16/07/2023-20/07/2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 22 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits^™. Information on the process to convert EACCME® credit to AMA credit can be found here.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Pharmacist Continuing Education

Postgraduate Institute for Medicine designates this continuing education activity for 26.75 contact hours (2.675 CEUs) of the Accreditation Council for Pharmacy Education.

Type of activity for all sessions: Application

Universal Activity Numbers:

• Sunday, July 16
  • Session 1 — JA4008162-9999-23-139-L04-P
  • Session 2 — JA4008162-9999-23-140-L04-P
  • Session 3 — JA4008162-9999-23-141-L04-P
  • Session 4 — JA4008162-9999-23-142-L04-P
  • Session 5 — JA4008162-9999-23-143-L04-P
• Monday, July 17
  • Session 1 — JA4008162-9999-23-144-L04-P
  • Session 2 — JA4008162-9999-23-145-L04-P
  • Session 3 — JA4008162-9999-23-146-L04-P
  • Session 4 — JA4008162-9999-23-147-L04-P
  • Session 5 — JA4008162-9999-23-148-L04-P
• Tuesday, July 18
  • Session 1 — JA4008162-9999-23-149-L04-P
  • Session 2 — JA4008162-9999-23-150-L04-P
  • Session 3 — JA4008162-9999-23-151-L04-P
  • Session 4 — JA4008162-9999-23-152-L04-P
  • Session 5 — JA4008162-9999-23-153-L04-P
• Wednesday, July 19
  • Session 1 — JA4008162-9999-23-154-L04-P
  • Session 2 — JA4008162-9999-23-155-L04-P
  • Session 3 — JA4008162-9999-23-156-L04-P
  • Session 4 — JA4008162-9999-23-157-L04-P
  • Session 5 — JA4008162-9999-23-158-L04-P
• Thursday, July 20
  • Session 1 — JA4008162-9999-23-159-L04-P
  • Session 2 — JA4008162-9999-23-160-L04-P
  • Session 3 — JA4008162-9999-23-161-L04-P

Psychologist Continuing Education

PIM is approved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibility for this program and its content. This program offers 26.75 continuing education credits for psychologists.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 26.75 contact hours.

Social Work Continuing Education

As a Jointly Accredited Organization, PIM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. PIM maintains responsibility for this course. Social workers completing this course receive 26.75 clinical continuing education credits.

Disclosure of Conflicts of Interest

PIM requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

A copy of the Speaker Disclosure of Conflicts of Interest report is available on the resource tab of the AAIC virtual platform.

The Alzheimer’s Association and PIM planners and others have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

How to Claim Credit

The certificate of attendance is complimentary to all attendees for both the virtual and in-person conference formats.